Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Glucose Metabolism in South Asian Women With IGT or IFG. DIAbetes in South Asians - DIASA 3: A 12-week Intervention Trial With Oral Antidiabetic Medication to Improve Hepatic and Whole Body Insulin Sensitivity

NCT04662866 is registered in ClinicalTrials.gov with Oslo University Hospital as lead sponsor.

NCT NCT04662866
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04662866 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Glucose Metabolism in South Asian Women With IGT or IFG. DIAbetes in South Asians - DIASA 3: A 12-week Intervention Trial With Oral Antidiabetic Medication to Improve Hepatic and Whole Body Insulin Sensitivity
Lead sponsor
Oslo University Hospital
Phase
Phase 2
Overall status
Unknown status
Start date
February 10, 2021
Completion date
October 31, 2023
Enrollment
64 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

glucose metabolism disorders, impaired glucose tolerance, insulin sensitivity